BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1722191)

  • 1. Effect of isoprinosine on IL-2, IFN-gamma and IL-4 production in vivo and in vitro.
    Milano S; Dieli M; Millott S; Miceli MD; Maltese E; Cillari E
    Int J Immunopharmacol; 1991; 13(7):1013-8. PubMed ID: 1722191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major.
    Cillari E; Dieli M; Lo Campo P; Sireci G; Caffarelli A; Maltese E; Millott S; Milano S; Liew FY
    Immunology; 1991 Sep; 74(1):25-30. PubMed ID: 1718853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.
    Heinzel FP; Sadick MD; Mutha SS; Locksley RM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of IL-2, IFN-gamma, TNF-alpha and IL-4 production in mice of different ages by thymopentin.
    Cillari E; Milano S; Perego R; Gromo G; D'Agostino R; Arcoleo F; Dieli M
    Int J Immunopharmacol; 1992 Aug; 14(6):1029-35. PubMed ID: 1428357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.
    Seder RA; Paul WE; Davis MM; Fazekas de St Groth B
    J Exp Med; 1992 Oct; 176(4):1091-8. PubMed ID: 1328464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
    Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
    Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production during infection with Hymenolepis diminuta in BALB/c mice.
    Palmas C; Bortoletti G; Gabriele F; Wakelin D; Conchedda M
    Int J Parasitol; 1997 Jul; 27(7):855-9. PubMed ID: 9279590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.
    Seder RA; Gazzinelli R; Sher A; Paul WE
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10188-92. PubMed ID: 7901851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
    O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
    Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.
    Diaz-Sanchez D; Noble A; Staynov DZ; Lee TH; Kemeny DM
    Immunology; 1993 Apr; 78(4):513-9. PubMed ID: 8495968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice.
    Fischbach M; Talal N
    Clin Exp Immunol; 1985 Aug; 61(2):242-7. PubMed ID: 2412742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
    Pedersen BK; Tvede N; Diamant M; Gerstoft J; Bagge Hansen M; Haahr PM; Hørding M; Kappel M; Klokker M; Søeberg B
    Scand J Immunol; 1990 Dec; 32(6):641-9. PubMed ID: 1702899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo recovery of IFN-gamma, but not IL-2, production by IL-12 in mice with plasma cell tumors.
    Ruzek MC; Mathur A
    Int Immunol; 1996 Mar; 8(3):413-22. PubMed ID: 8671628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats.
    Exon JH; Henningsen GM; Koller LD; Talcott PA
    Int J Immunopharmacol; 1986; 8(1):53-62. PubMed ID: 2420733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice.
    Karpuzoglu-Sahin E; Zhi-Jun Y; Lengi A; Sriranganathan N; Ansar Ahmed S
    Cytokine; 2001 May; 14(4):208-17. PubMed ID: 11448120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
    Wiranowska-Stewart M; Hadden JW
    Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.